Invivyd Inc

NASDAQ:IVVD   4:00:00 PM EDT
0.70
-0.04 (-5.99%)
7:39:23 PM EDT: $0.71 +0.01 (+1.18%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)84.12M
Current PEN/A
Forward PE N/A
2yr Forward PE 0.73
See more stats
Estimates Current Quarter
Revenue$23.16 Million
Adjusted EPS-$0.02
See more estimates
10-Day MA$0.79
50-Day MA$0.73
200-Day MA$0.82
See more pivots

Invivyd Inc Stock, NASDAQ:IVVD

1601 Trapelo Road, Suite 178, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.819.0080
Number of Employees: 99

Description

Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.